These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19242968)

  • 1. Desmoid cell motility is induced in vitro by rhEGF.
    Joyner DE; Trang SH; Damron TA; Aboulafia AJ; Cummings JE; Randall RL
    J Orthop Res; 2009 Sep; 27(9):1258-62. PubMed ID: 19242968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
    Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
    J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines associated with the pathophysiology of aggressive fibromatosis.
    Mills BG; Frausto A; Brien E
    J Orthop Res; 2000 Jul; 18(4):655-62. PubMed ID: 11052503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.
    Stabellini G; Balducci C; Lilli C; Marinucci L; Becchetti E; Carinci F; Calastrini C; Dolci C; Lumare E; Locci P
    Biomed Pharmacother; 2008 Sep; 62(7):436-42. PubMed ID: 18155395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro.
    Lund-Johansen M; Bjerkvig R; Humphrey PA; Bigner SH; Bigner DD; Laerum OD
    Cancer Res; 1990 Sep; 50(18):6039-44. PubMed ID: 2393868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
    Ito I; Fixman ED; Asai K; Yoshida M; Gounni AS; Martin JG; Hamid Q
    Clin Exp Allergy; 2009 Sep; 39(9):1370-80. PubMed ID: 19522858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
    Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
    Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmoid and fibroma tumors differently respond to TGFbeta(1) stimulus and ECM macromolecule accumulation.
    Locci P; Balducci C; Lilli C; Marinucci L; Becchetti E; Dolci C; Calastrini C; Lumare E; Stabellini G
    Biomed Pharmacother; 2007; 61(2-3):131-6. PubMed ID: 17145161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine regulation of human urothelial cell proliferation and migration during regenerative responses in vitro.
    Varley C; Hill G; Pellegrin S; Shaw NJ; Selby PJ; Trejdosiewicz LK; Southgate J
    Exp Cell Res; 2005 May; 306(1):216-29. PubMed ID: 15878346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
    Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH; Song YC; Kim SH; Jo H; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential for functional redundancy in EGF and TGFalpha signaling in desmoid cells: a cDNA microarray analysis.
    Trang SH; Joyner DE; Damron TA; Aboulafia AJ; Randall RL
    Growth Factors; 2010 Feb; 28(1):10-23. PubMed ID: 20092031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair.
    Hardwicke J; Ferguson EL; Moseley R; Stephens P; Thomas DW; Duncan R
    J Control Release; 2008 Sep; 130(3):275-83. PubMed ID: 18700156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells.
    Westermark B; Magnusson A; Heldin CH
    J Neurosci Res; 1982; 8(2-3):491-507. PubMed ID: 6296418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor-induced ovarian carcinoma cell migration is associated with JAK2/STAT3 signals and changes in the abundance and localization of alpha6beta1 integrin.
    Colomiere M; Findlay J; Ackland L; Ahmed N
    Int J Biochem Cell Biol; 2009 May; 41(5):1034-45. PubMed ID: 18930836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine-rich domains of muc3 intestinal mucin promote cell migration, inhibit apoptosis, and accelerate wound healing.
    Ho SB; Dvorak LA; Moor RE; Jacobson AC; Frey MR; Corredor J; Polk DB; Shekels LL
    Gastroenterology; 2006 Nov; 131(5):1501-17. PubMed ID: 17101324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of Ral A in epidermal growth factor receptor-regulated cell motility.
    Gildea JJ; Harding MA; Seraj MJ; Gulding KM; Theodorescu D
    Cancer Res; 2002 Feb; 62(4):982-5. PubMed ID: 11861368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The core-aldehyde 9-oxononanoyl cholesterol increases the level of transforming growth factor beta1-specific receptors on promonocytic U937 cell membranes.
    Gargiulo S; Gamba P; Sottero B; Biasi F; Chiarpotto E; Serviddio G; Vendemiale G; Poli G; Leonarduzzi G
    Aging Cell; 2009 Apr; 8(2):77-87. PubMed ID: 19302374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioresponsive dextrin-rhEGF conjugates: in vitro evaluation in models relevant to its proposed use as a treatment for chronic wounds.
    Hardwicke J; Moseley R; Stephens P; Harding K; Duncan R; Thomas DW
    Mol Pharm; 2010 Jun; 7(3):699-707. PubMed ID: 20166755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering epidermal growth factor for enhanced mitogenic potency.
    Reddy CC; Niyogi SK; Wells A; Wiley HS; Lauffenburger DA
    Nat Biotechnol; 1996 Dec; 14(13):1696-9. PubMed ID: 9634854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.